Bronchodilator Response as a Possible Predictor of Lung Function Improvement After Pulmonary Rehabilitation in Post-COVID-19 Patients

Arch Bronconeumol. 2022 Jun;58(6):517-519. doi: 10.1016/j.arbres.2021.06.004. Epub 2021 Jun 18.

Authors

Mauro Maniscalco¹, Salvatore Fuschillo¹, Pasquale Ambrosino¹, Silvestro Ennio D'Anna¹, Maria Sofia Accardo¹, Maria Gabriella Matera², Mario Cazzola³

Affiliations

¹ Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy.
² Unit of Pharmacology, Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.
³ Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome "Tor Vergata", Rome, Italy.

No abstract available

Publication types

Case Reports

MeSH terms

Bronchodilator Agents / therapeutic use
COVID-19*
Forced Expiratory Volume
Humans
Lung / diagnostic imaging
Pulmonary Disease, Chronic Obstructive* / complications
Pulmonary Disease, Chronic Obstructive* / drug therapy

Substances

Bronchodilator Agents